Interleukin.5 (IL.5) is the main eosinophilic cytokine that promotes the differentiation, survival, and activation of eosinophils, which are the key inflammatory cells in severe eosinophilic asthma .Thus, it is no surprise that anti.IL.5 pathways have been explored for several years for their ability to reduce eosinophilic inflammation and thus to improve the treatment of this disease.
We Have to Learn to Do Without Knowing Enough: Anti-Eosinophilic Treatments for Severe Asthma / Papi, A1; Beghe', Bianca; Fabbri, Lm3; 4,. - In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. - ISSN 1073-449X. - 197:1(2018), pp. 1-7. [10.1164/rccm.201710-1970ED]
We Have to Learn to Do Without Knowing Enough: Anti-Eosinophilic Treatments for Severe Asthma
BEGHE', Bianca;
2018
Abstract
Interleukin.5 (IL.5) is the main eosinophilic cytokine that promotes the differentiation, survival, and activation of eosinophils, which are the key inflammatory cells in severe eosinophilic asthma .Thus, it is no surprise that anti.IL.5 pathways have been explored for several years for their ability to reduce eosinophilic inflammation and thus to improve the treatment of this disease.
| File | Dimensione | Formato | |
|---|---|---|---|
|
rccm.201710-1970ed.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
126.81 kB
Formato
Adobe PDF
|
126.81 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
